Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Max R. Trenerry"'
Autor:
Zachary A. Buchholtz, Max R. Trenerry, Sarah E. Baker, Timothy B. Curry, Michael J. Joyner, Chad C. Wiggins, Haider R. Clifton, John R. A. Shepherd, Koji Uchida, David R. Holmes, Jonathon W. Senefeld
Publikováno v:
Aerospace Medicine and Human Performance. 91:839-844
INTRODUCTION: Exposure to low oxygen environments (hypoxia) can impair cognitive function; however, the time-course of the transient changes in cognitive function is unknown. In this study, we assessed cognitive function with a cognitive test before,
Autor:
Timothy B. Curry, Jonathon W. Senefeld, Michael J. Joyner, Max R. Trenerry, Chad C. Wiggins, Sarah E. Baker, John R. A. Shepherd, Koji Uchida, Haider R. Clifton, David R. Holmes
Publikováno v:
The FASEB Journal. 34:1-1
Autor:
Haider R. Clifton, David R. Holmes, Sarah E. Baker, Michael J. Joyner, Koji Uchida, Zachary A. Buchholtz, Chad C. Wiggins, Max R. Trenerry, Timothy B. Curry
Publikováno v:
The FASEB Journal. 34:1-1
Publikováno v:
Journal of Clinical Lipidology. 13:e38-e39
Autor:
Jamie J. Van Gompel, Joel P. Felmlee, Vivek Gupta, Max R. Trenerry, David A. Woodrum, Amy Z. Crepeau, Gregory A. Worrell, Prasanna Vibhute, Benjamin H. Brinkmann, Sanjeet S. Grewal, William O. Tatum, Robert E. Wharen, Richard S. Zimmerman, Joseph M. Hoxworth, Robert E. Watson, Krzysztof R. Gorny, W. Richard Marsh, Timothy J. Kaufmann
Publikováno v:
Journal of neurosurgery.
OBJECTIVEAlthough it is still early in its application, laser interstitial thermal therapy (LiTT) has increasingly been employed as a surgical option for patients with mesial temporal lobe epilepsy. This study aimed to describe mesial temporal lobe a
Autor:
Tali Bayer-Topilsky, Maurice Enriquez-Sarano, Rakesh M. Suri, Hartzell V. Schaff, Max R. Trenerry, Yariv N. Marmor, Douglas W. Mahoney, Yan Topilsky, Ryan M. Antiel
Publikováno v:
The American Journal of Medicine. 126:916-924
To define the prevalence and consequences of post-traumatic stress disorder (PTSD) as an emotional response to cardiac diseases in patients with mitral regurgitation.We prospectively enrolled 186 patients with moderate or severe organic mitral regurg
Autor:
Ryan M. Antiel, Tali Bayer-Topilsky, Hartzell V. Schaff, Maurice Enriquez-Sarano, Yan Topilsky, Max R. Trenerry, Yariv N. Marmor, Douglas W. Mahoney, Rakesh M. Suri
Publikováno v:
The American journal of medicine. 129(10)
Objective The purpose of this study is to investigate whether mitral valve prolapse is associated with the patient's psychoemotional status and health-related quality of life. Methods Mitral valve prolapse and mitral regurgitation were prospectively
Autor:
Keith A. Josephs, Jennifer L. Whitwell, J. Eric Ahlskog, Clifford R. Jack, Jonathan Graff-Radford, Michael D. Jensen, Max R. Trenerry
Publikováno v:
Journal of Clinical Neuroscience. 18:1671-1676
Recently, we have identified a series of patients presenting with cognitive complaints after gastric bypass, without any identifiable etiology. We aimed to determine if focal brain atrophy could account for the complaints. A retrospective case series
Autor:
Daniel A. Drubach, Max R. Trenerry, Sean J. Pittock, Paula A. Aston, Kristin J. Somers, Christopher J. Klein, Daniel H. Lachance, Vanda A. Lennon, Andrew McKeon, James R. Rundell
Publikováno v:
The Journal of Neuropsychiatry and Clinical Neurosciences. 23:425-433
The authors describe the neuropsychiatric spectrum of voltage-gated potassium-channel complex (VGKC) autoimmunity among 67 seropositive patients; 2 had initially been assigned a primary psychiatric diagnosis. Diverse manifestations were recorded, oft
Autor:
Daniel A. Drubach, Bradley F. Boeve, Keith A. Josephs, Max R. Trenerry, Eoin P. Flanagan, Joseph E. Parisi, Jayawant N. Mandrekar, Andrew McKeon, Jeffrey W. Britton, Sean J. Pittock, Val J. Lowe, Vanda A. Lennon, K. Meng Tan
Publikováno v:
Mayo Clinic Proceedings. 85:881-897
OBJECTIVE To define the diagnostic characteristics and predictors of treatment response in patients with suspected autoimmune dementia. PATIENTS AND METHODS Between January 1, 2002, and January 1, 2009, 72 consecutive patients received immunotherapy